• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • US
    • Sandoz Site Directory
Home
  • Home
  • Our Work
    • What We Do
    • Disease Areas
    • Quality Generics
    • Biosimilars
    • Partnerships and Collaborations
    • Access to Healthcare
  • About Us
    • Who We Are
    • Corporate Responsibility
    • For Novartis Investors
    • Contact Us
    • Doing Business Responsibly
  • Patients & Customers
    • Report Side Effects
    • Product Safety Notices
    • Information for Customers
    • Products
  • News
    • US Press Releases & News
    • Media Contacts
    • Publications
  • Careers
    • Job Search
    • Working at Sandoz US
    • Diversity & Inclusion
Search

All News

Advanced SearchBasic Search
2015

March

Media Release / Mar 06, 2015

FDA approves first biosimilar Zarxio™ (filgrastimsndz)

Read More
Search Results Navigation
  • First page « first
  • Previous page ‹ previous
  • …
  • Page 7 of 5
  • Page 8 of 5
  • Page 9 of 5
  • Page 10 of 5
  • Current page 11 of 5
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
    • Jump to Comments
  • Print
  • Save

You are here

  1. Home ›
  2. News ›

Sandoz United States

  • Our Work
  • About Us
  • News
  • Careers
  • Contact Us
  • Locations

Subscribe to Sandoz

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • RSS
  • Sandoz Site Directory
© 2022 Sandoz AG

This site is intended for a US audience

  • Terms of Use
  • Privacy Policy
  • About Cookies
  • Legal Notice